Sree Rayalaseema Hi-Strength Hypo Ltd
Incorporated in 2005, Sree Rayalaseema
Hi – Strength Hypo Ltd is a producer of
producer of Calcium Hypo -chloride,
Stable Bleaching Powder, Sulphuric
Acid and other chemicals[1]
- Market Cap ₹ 842 Cr.
- Current Price ₹ 490
- High / Low ₹ 717 / 381
- Stock P/E 8.39
- Book Value ₹ 566
- Dividend Yield 0.61 %
- ROCE 14.0 %
- ROE 10.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.87 times its book value
Cons
- The company has delivered a poor sales growth of -6.04% over past five years.
- Company has a low return on equity of 10.8% over last 3 years.
- Earnings include an other income of Rs.41.2 Cr.
- Dividend payout has been low at 5.98% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 362 | 164 | 689 | 911 | 1,267 | 1,650 | 866 | 638 | 667 | |
| 318 | 142 | 587 | 781 | 1,119 | 1,470 | 755 | 546 | 578 | |
| Operating Profit | 44 | 22 | 102 | 130 | 149 | 180 | 111 | 92 | 88 |
| OPM % | 12% | 13% | 15% | 14% | 12% | 11% | 13% | 14% | 13% |
| 2 | 0 | 4 | 7 | 11 | 34 | 11 | 36 | 41 | |
| Interest | 11 | 3 | 10 | 5 | 3 | 5 | 4 | 2 | 2 |
| Depreciation | 10 | 10 | 50 | 51 | 19 | 19 | 11 | 7 | 7 |
| Profit before tax | 25 | 9 | 45 | 81 | 137 | 190 | 107 | 119 | 121 |
| Tax % | 27% | -1% | 17% | 25% | 25% | 19% | 26% | 27% | 25% |
| 25 | 9 | 38 | 61 | 103 | 154 | 79 | 87 | 90 | |
| EPS in Rs | 17.02 | 5.64 | 22.09 | 35.29 | 59.88 | 89.86 | 46.06 | 52.47 | 52.52 |
| Dividend Payout % | 9% | 25% | 11% | 8% | 6% | 4% | 7% | 6% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -6% |
| 3 Years: | -26% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 11% |
| 3 Years: | -11% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 7% |
| 3 Years: | -7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 11% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 189 | 182 | 294 | 371 | 553 | 734 | 783 | 901 | 954 |
| 85 | 79 | 57 | 72 | 28 | 19 | 13 | 16 | 12 | |
| 84 | 64 | 76 | 59 | 189 | 175 | 100 | 136 | 133 | |
| Total Liabilities | 372 | 340 | 445 | 519 | 788 | 945 | 914 | 1,070 | 1,115 |
| 195 | 187 | 161 | 134 | 130 | 105 | 128 | 135 | 132 | |
| CWIP | 2 | 0 | 3 | 0 | 0 | 14 | 0 | 0 | 0 |
| Investments | 39 | 23 | 18 | 50 | 164 | 268 | 253 | 349 | 307 |
| 137 | 129 | 262 | 334 | 494 | 558 | 534 | 585 | 677 | |
| Total Assets | 372 | 340 | 445 | 519 | 788 | 945 | 914 | 1,070 | 1,115 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 21 | -8 | 99 | 71 | 60 | 141 | 140 | 65 | 39 | |
| -9 | -1 | -38 | -115 | -1 | -112 | -20 | -8 | 37 | |
| -12 | 11 | -22 | 10 | -51 | -17 | -17 | -18 | -11 | |
| Net Cash Flow | -0 | 2 | 40 | -35 | 7 | 13 | 103 | 40 | 65 |
| Free Cash Flow | 14 | -9 | 91 | 50 | 45 | 133 | 120 | 63 | 38 |
| CFO/OP | 63% | -35% | 108% | 82% | 62% | 122% | 152% | 105% | 74% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 117 | 43 | 39 | 38 | 33 | 45 | 59 | 46 |
| Inventory Days | 37 | 49 | 36 | 27 | 62 | 39 | 24 | 50 | 55 |
| Days Payable | 39 | 16 | 24 | 8 | 33 | 22 | 10 | 18 | 13 |
| Cash Conversion Cycle | 51 | 150 | 55 | 57 | 67 | 50 | 59 | 91 | 88 |
| Working Capital Days | -2 | 53 | 24 | 23 | 47 | 42 | 59 | 82 | 87 |
| ROCE % | 4% | 21% | 26% | 26% | 15% | 14% | 14% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Calcium Hypochlorite Production Volume MT ・Standalone data |
|
||||||
| Calcium Hypochlorite Sales Volume MT ・Standalone data |
|||||||
| Power Consumption per MT - Calcium Hypochlorite KWH/MT ・Standalone data |
|||||||
| Stable Bleaching Powder (SBP) Production Volume MT ・Standalone data |
|||||||
| Stable Bleaching Powder (SBP) Sales Volume MT ・Standalone data |
|||||||
| Sulphuric Acid Production Volume MT ・Standalone data |
|||||||
| Sulphuric Acid Capacity TPD ・Standalone data |
|||||||
| Sulphuric Acid Sales Volume MT ・Standalone data |
|||||||
| Thermal Power Plant Capacity MW ・Standalone data |
|||||||
| Sodium Methoxide Powder Capacity MT per month ・Standalone data |
|||||||
| Sodium Methoxide Solution Capacity MT per month ・Standalone data |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Jun - Submission of newspaper publications with regard to special window for lodgement/ relodgement of transfer requests and Saksham Niveshak- 100 days second campaign published in Business …
-
Submission Of Report- Special Window
6 Jun - May 2026 special-window physical share re-lodgement report shows nil requests received, processed, approved, or rejected.
-
Submission Of Report- Special Window
1 Jun - Reported April 2026 re-lodgment status: 1 request received, under process.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Submission of newspaper publications of extract of audited standalone and consolidated financial results for quarter/ year ending 31-03-2026 published in Business standard and Andhra Prabha …
-
Board Meeting Outcome for Submission Of Standalone And Consolidated Audited Financial Results For 4Th Quarter/ Year Ending 31.03.2026 Recommendation Of Final Dividend And Reappointment Of Internal And Cost Auditors
30 May - Board approved FY26 audited results, recommended Rs3/share final dividend, and reappointed internal and cost auditors.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Segments